Search for Clinical Trial Results

Leukemia, Eosinophilic, Acute - 25 Studies Found
Status | Study |
Terminated |
Study Name: Idarubicin and Cytarabine With or Without Bevacizumab in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Condition:
|
Completed |
Study Name: Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid Leukemia Condition:
|
Active, not recruiting |
Study Name: Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia Condition:
|
Terminated |
Study Name: Eltrombopag Olamine in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia Condition:
|
Terminated |
Study Name: Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia Condition:
|
Completed |
Study Name: Alvocidib, Cytarabine, and Mitoxantrone in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Condition:
|
Completed |
Study Name: Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast Phase Condition:
|
Completed |
Study Name: Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia Condition:
|
Completed |
Study Name: Sorafenib in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndromes, or Blastic Phase Chronic Myelogenous Leukemia Condition:
|
Completed |
Study Name: Sorafenib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia Condition:
|